Biotech start-up receives funding for muscular dystrophies
News / 7 September 2022
A new biotech company led by Professor Peter Currie and Associate Professor Mikaël Martino, will receive more than half a million dollars to develop much-needed new therapies for the treatment of debilitating muscular dystrophies.